Berman Capital Advisors’s Pediatrix Medical MD Stock Holding History

Berman Capital Advisors’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$16K	Buy	577 +10	+2%	+$305	﹤0.01%	1051
2021 Q2	$17K	Hold	567	–	–	﹤0.01%	967
2021 Q1	$14K	Hold	567	–	–	﹤0.01%	920
2020 Q4	$13K	Sell	567 -28	-5%	-$526	﹤0.01%	821
2020 Q3	$9K	Hold	595	–	–	﹤0.01%	842
2020 Q2	$10K	Buy	595 +95	+19%	+$1.41K	﹤0.01%	764
2020 Q1	$4K	Buy	500 +385	+335%	+$7.94K	﹤0.01%	951
2019 Q4	$3K	Buy	+115	New	+$2.88K	﹤0.01%	1112
2019 Q3	–	Sell	-64	Closed	-$1K	–	1524
2019 Q2	$1K	Buy	+64	New	+$1.72K	﹤0.01%	1350
2019 Q1	–	Sell	-58	Closed	-$1K	–	1419
2018 Q4	$1K	Buy	+58	New	+$2.33K	﹤0.01%	1029

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Berman Capital Advisors's MD Position: Q3 2021 in Review

Berman Capital Advisors increased its Pediatrix Medical (MD) stake by 1.8% in Q3 2021, buying an estimated $305 and bringing the position to 577 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #1051.

Berman Capital Advisors first reported a position in MD in Q4 2018 and has held it in 10 quarters since. The position peaked at $17K in Q2 2021. 220 funds tracked by Wall St. Rank hold MD as of Q3 2021.

Berman Capital Advisors held 577 shares of Pediatrix Medical worth $16K as of Q3 2021.
Berman Capital Advisors bought 10 Pediatrix Medical shares in Q3 2021, an estimated $305.
Pediatrix Medical made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1051 holding.
Berman Capital Advisors first reported a position in Pediatrix Medical in Q4 2018 and has held it in 10 quarters since.
Berman Capital Advisors's Pediatrix Medical position peaked at $17K in Q2 2021.
220 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.